Skip to main content
OpenTrials

Clinical trial condition

Primary Myelofibrosis

Explore clinical trials studying Primary Myelofibrosis. Study availability and eligibility vary by location and protocol.

453 public trials 89 recruiting studies
Refine in advanced search Browse all conditions

Primary Myelofibrosis trial results

Completed

Controlled Myelofibrosis Study With Oral Janus-associated Kinase (JAK) Inhibitor Treatment-II: The COMFORT-II Trial

NCT00934544

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Novartis Investigative Site Innsbruck, Austria
  • Novartis Investigative Site Linz, Austria
  • Novartis Investigative Site Salzburg, Austria
  • Novartis Investigative Site Vienna, Austria
View all 61 locations
View Trial Details
Completed

A Two-part Study to Assess the Safety and Preliminary Efficacy of Givinostat in Patients With Polycythemia Vera

NCT01901432

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +12 more
Locations
  • CHU Amiens - Hôpital Sud Amiens, France
  • Hôpital Morvan - CHRU de Brest Brest, France
  • Hopital Saint Vincent de Paul - GHICL Lille Lille, France
  • Hôpital Saint-Louis (AP-HP), Centre Investigations Cliniques Paris, France
View all 25 locations
View Trial Details
Completed

Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence

NCT01178281

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • UCLA School of Medicine Los Angeles, California, United States
  • University of Florida Shands Cancer Center Gainesville, Florida, United States
  • Mayo Clinic Jacksonville, Florida, United States
View all 87 locations
View Trial Details
Completed

Research Tissue Bank

NCT00666549

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +15 more
Locations
  • Palo Alto Medical Foundation Research Institute Palo Alto, California, United States
  • Weill Cornell University Washington D.C., District of Columbia, United States
  • University of Georgetown Washington D.C., District of Columbia, United States
  • University of Illinois at Chicago Chicago, Illinois, United States
View Trial Details
Completed

Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation

NCT02311569

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +14 more
Locations
  • Kantonsspital Aarau Aarau, Switzerland
  • Universitaetsspital-Basel Basel, Switzerland
  • Istituto Oncologico della Svizzera Italiana - Ospedale San Giovanni Bellinzona, Switzerland
  • Inselspital Bern Bern, Switzerland
View Trial Details
Completed

INC424 for Patients With Primary Myelofibrosis, Post Polycythemia Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis.

NCT01493414

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Novartis Investigative Site Algiers, Algeria
  • Novartis Investigative Site CABA, Buenos Aires, Argentina
  • Novartis Investigative Site CABA, Buenos Aires, Argentina
  • Novartis Investigative Site Paraná, Entre Ríos Province, Argentina
View all 273 locations
View Trial Details

Related conditions